Marty Makary

Extracted Attributes

• Awards

  Nobility in Science Award (National Pancreas Foundation); 2020 Business Book of the Year

• Education

  Bucknell University (BS), Jefferson Medical College (MD), Harvard School of Public Health (MPH)

• Full Name

  Martin Adel Makary

• Nationality

  British-American

• Academic Rank

  Professor of Surgery and Mark Ravitch Chair in Gastrointestinal Surgery

• Current Position

  27th Commissioner of Food and Drugs (FDA)

• Publication Count

  Over 300 peer-reviewed articles

• Medical Specialties

  Surgical oncology, gastrointestinal laparoscopic surgery, islet transplant surgery

• Scientific Contributions

  Pioneered laparoscopic Whipple and Frey’s procedures; co-developer of the WHO Surgery Checklist

Timeline

• Elected to the National Academy of Medicine. (Source: Wikipedia)

  2018-01-01

• Received the Business Book of the Year Award for 'The Price We Pay'. (Source: Congress.gov Witness Bio)

  2020-01-01

• Nominated by President-elect Donald Trump to serve as the Commissioner of the FDA. (Source: Wikipedia)

  2024-11-22

• Detailed the FDA reform agenda during the JP Morgan Healthcare Conference in San Francisco, California. (Source: Document 065d2e96-4d40-49bd-8511-d8d35f8b01f4)

  2025-01-13

• Confirmed by a bipartisan vote of the U.S. Senate as the 27th Commissioner of Food and Drugs. (Source: FDA Official Biography)

  2025-03-25

Marty Makary

Martin Adel Makary () is a British-American surgeon, professor, author, and medical commentator who has served as the 27th commissioner of food and drugs since 2025. He practices surgical oncology and gastrointestinal laparoscopic surgery at Johns Hopkins Hospital, is Mark Ravitch Chair in Gastrointestinal Surgery at Johns Hopkins School of Medicine, and is the chief of Islet Transplant Surgery at Johns Hopkins. Makary completed his surgical residency at Georgetown University and sub-specialty training in surgical oncology and gastrointestinal surgery at Johns Hopkins under John Cameron, later joining Cameron’s faculty practice. Makary has pioneered advanced laparoscopic procedures, including the first laparoscopic Whipple and Frey’s procedures at Johns Hopkins, and led the development of “the Surgery Checklist” in collaboration with the World Health Organization. Makary has held several leadership roles at Johns Hopkins, including Credentials Chair, Director of Quality and Safety for Surgery, clinical lead for the Sibley Innovation Hub, and Executive Director of Improving Wisely. He has published extensively on surgical safety, frailty, teamwork, and hospital quality, and has advocated for public reporting of physician-endorsed quality measures, price transparency, and reform in drug pricing. Makary is also a bestselling author, with works including Unaccountable, The Price We Pay, Mama Maggie, and Blind Spots, focusing on improving healthcare systems, critical evaluation of medical practices, and personal narratives of humanitarian work. In 2018, he was elected to the National Academy of Medicine. Some of his research and commentary has been controversial, including a widely cited paper claiming medical error is the third leading cause of death in the United States. During the COVID-19 pandemic, Makary supported universal masking early on and vaccines for adults, but opposed broad vaccine mandates, certain school and university restrictions, and boosters for younger populations. In November 2024, President-elect Donald Trump announced Makary would be his nominee to head the Food and Drug Administration (FDA) as its commissioner. He was confirmed by the United States Senate in March 2025. As FDA commissioner, Makary has prioritized modernizing regulatory processes, launching AI-assisted review tools, and incorporating anecdotal evidence in food safety decisions.

Web Search Results

• Marty Makary - Wikipedia

  Martin Adel Makary (/məˈkæri/) is a British-American surgeon, professor, author, and medical commentator who has served as the 27th commissioner of food and drugs since 2025. He practices surgical oncology and gastrointestinal laparoscopic surgery at Johns Hopkins Hospital, is Mark Ravitch Chair in Gastrointestinal Surgery at Johns Hopkins School of Medicine, and is the chief of Islet Transplant Surgery at Johns Hopkins. Makary completed his surgical residency at Georgetown University and sub-specialty training in surgical oncology and gastrointestinal surgery at Johns Hopkins under John Cameron, later joining Cameron’s faculty practice. [...] Makary has pioneered advanced laparoscopic procedures, including the first laparoscopic Whipple and Frey’s procedures at Johns Hopkins, and led the development of “the Surgery Checklist” in collaboration with the World Health Organization. Makary has held several leadership roles at Johns Hopkins, including Credentials Chair, Director of Quality and Safety for Surgery, clinical lead for the Sibley Innovation Hub, and Executive Director of Improving Wisely. He has published extensively on surgical safety, frailty, teamwork, and hospital quality, and has advocated for public reporting of physician-endorsed quality measures, price transparency, and reform in drug pricing. [...] Makary is a pancreatic surgeon and has pioneered novel surgical procedures. He was awarded the Nobility in Science Award by the National Pancreas Foundation for performing the world's first series of laparoscopic pancreas islet transplant operations. He has traveled with his international team overseas. Makary specializes in advanced laparoscopic surgery and performed the first laparoscopic Whipple surgery at Johns Hopkins and the first laparoscopic Frey's procedure for pancreatitis.

• [PDF] MARTY MAKARY M - Congress.gov

  Marty Makary M.D., M.P.H., F.A.C.S. Professor, Johns Hopkins University School of Medicine Dr. Martin Makary is professor at the Johns Hopkins University School of Medicine and a member of the National Academy of Medicine. He served in leadership at the World Health Organization and has published over 250 scientific articles including studies on Covid-19. A public health and public policy researcher, he leads a Johns Hopkins project on the “re-design of health care” to make health care more reliable and more affordable, especially for vulnerable populations. He is the recipient of the 2020 Business Book of the Year Award for his most New York Times bestselling book, The Price We Pay, about rising medical prices in America and the grassroots movement to increase health care transparency. [...] grassroots movement to increase health care transparency. Clinically, Dr. Makary is the chief of Islet Transplant Surgery at Johns Hopkins and is the recipient of the Nobility in Science Award from the National Pancreas Foundation. He has been a visiting professor at over 25 medical schools and has written extensively on the critical appraisal of scientific research and the evaluation of new medical interventions. He was the first editor-in-chief of Medpage Today and is currently on the editorial board of Sensible Medicine. He has written for the Wall Street Journal and the Washington Post. Dr. Makary is a graduate of Bucknell University, Jefferson Medical College, and the Harvard School of Public Health. He completed a surgical residency at Georgetown University and his sub-specialty [...] residency at Georgetown University and his sub-specialty training at Johns Hopkins.

• Martin Makary | FDA

  Dr. Marty Makary was confirmed on March 25, 2025 by a bipartisan vote of the U.S. Senate as the 27th Commissioner of Food and Drugs. Prior to joining the FDA, Dr. Makary worked at Johns Hopkins University School of Medicine, where he was a surgical oncologist and chief of Islet Transplant Surgery. After six years on the faculty at JHU, Dr. Makary was named an endowed chair in gastrointestinal surgery, and subsequently promoted to full professor with tenure. He also served as a professor at the Johns Hopkins Carey Business School and founded the Johns Hopkins Center for Surgical Trials and Outcomes Research. [...] Dr. Makary is a widely published writer, having authored more than 300 peer-reviewed articles in medical journals. He is the author of three New York Times bestselling books on health care, including: “Unaccountable – What Hospitals Tell You and How Transparency Can Revolutionize Health Care;” “The Price We Pay,” which examined health care costs; and which was named 2020 Business Book of the Year by the Association of Business Journalists; and “Blind Spots -- When Medicine Gets It Wrong, and What It Means for Our Health,” which presents the latest scientific research on the microbiome, food and other health topics. [...] Dr. Makary has led cross-disciplinary research on a range of subjects, including cancer care, obesity, frailty and psychologic reserve in older patients, adverse event monitoring, the Orphan Drug Act, antimicrobial resistance, and Alzheimer’s. Of particular note, he is the co-developer of the Surgery Checklist used in many operating rooms around the world today. Dr. Makary was the first to perform several novel surgical operations, including the first-in-the-world series of laparoscopic pancreas islet transplant operations. For his pioneering work, Dr. Makary was awarded the Nobility in Science Award from the National Pancreas Foundation. For the last 22 years, he has had an active clinical practice.

• Marty Makary M.D.

  ### Dr. Marty Makary is a New York Times bestselling author and health care expert at Johns Hopkins University. He writes for The Wall Street Journal and served in leadership at the World Health Organization. Marty is the recipient of the 2020 Business Book of the Year Award for his most recent book, The Price We Pay, which has been described by Steve Forbes as “A must-read for every American”. His newest book, BLIND SPOTS, explores the latest scientific research or major health topics today where medical dogma has loomed large. A public health researcher, Dr. Makary leads efforts to improve the health of communities and focuses on the “re-design of health care” to make health care more reliable, holistic, and coordinated, especially for vulnerable populations. He leads national efforts [...] ### Alejo JL, Mitchell J, Chang A, Chiang TPY, Massie AB, Segev DL, Makary MA. # PubMed Comparison of US Hospital Cash Prices and Commercial Negotiated Prices for 70 Services ### Jiang JX, Makary MA, Bai G. # PubMed Evaluation of a Physician Peer-Benchmarking Intervention for Practice Variability and Costs for Endovenous Thermal Ablation ### Stonko DP, Dun C, Walsh C, Schul M, Blebea J, Boyle EM, Makary MA, Hicks CW. # PubMed Commercial Negotiated Prices for CMS-specified Shoppable Radiology Services in U.S. Hospitals ### Jiang JX, Makary MA, Bai G. # PubMed Commercial negotiated prices for CMS-specified shoppable surgery services in U.S. hospitals ### Jiang JX, Makary MA, Bai G. # PubMed [...] 3.3 to 4.7 times as effective in preventing Covid infection compared with vaccination...

• FDA Increases Flexibility on Requirements for Cell and Gene ...

  “Regulatory flexibility must be tailored for cell and gene therapies,” said FDA Commissioner Marty Makary, M.D., M.P.H. “These are common-sense reforms that will address the unique characteristics of cell and gene therapies and foster more innovation.” Over the last decade, the FDA’s Center for Biologics Evaluation and Research (CBER) has approved close to 50 CGTs. The transformative potential of these therapies has captured the imagination of the patient community and ignited product development.

• Image

  

• Gender

  male

• Educated At

  Thomas Jefferson University

• Instance Of

  Q5

• Occupation

  surgeon

• Citizenship

  United States

• Place Of Birth

  Liverpool